ASHLYN CASEY: Open Payments
NPI 1538991039 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,680 in 39 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $284 · 2025 $1,680
Food & beverage: $1,079Travel & lodging: $601
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 5 | $926 |
| ABBVIE INC. | 14 | $360 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $139 |
| Collegium Pharmaceutical, Inc. | 6 | $98 |
| Saluda Medical Americas, Inc. | 3 | $65 |
| Curonix LLC | 1 | $31 |
| DePuy Synthes Sales Inc. | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $14 |
Products named: General - Therapies, QULIPTA, RELISTOR, WaveWriter Alpha Prime 16, Belbuca, Evoke, BOTOX, PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A.
Industry payments across TX — which companies pay providers there.
